Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Psychiatry Rep. 2011 Aug;13(4):274-82. doi: 10.1007/s11920-011-0200-8.

Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets.

Author information

1
Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. p.p.dekoning@amc.uva.nl

Abstract

Obsessive-compulsive disorder (OCD) is a chronic psychiatric disorder that affects 2% of the general population. Despite optimal cognitive-behavioral and pharmacologic therapy, approximately 10% of patients remain treatment resistant. Currently, deep brain stimulation (DBS) is being investigated as an experimental therapy for treatment-refractory OCD. This review focuses on the efficacy and adverse events of all published DBS targets for OCD: anterior limb of the internal capsule, ventral striatum/ventral capsule, nucleus accumbens, nucleus subthalamicus, and inferior thalamic peduncle. Small studies with various designs indicate an overall average Yale-Brown Obsessive Compulsive Scale score decrease ranging from 6.8 to 31 points. The average overall responder rate is ±50%. The frequency of adverse events seems to be limited. Larger prospective studies including neuroimaging are needed to estimate adequately the true potential of DBS in treatment of OCD and to elucidate its underlying mechanism of action and optimal brain target. We conclude that DBS may be a promising and safe therapy for treatment-resistant OCD.

PMID:
21505875
DOI:
10.1007/s11920-011-0200-8
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center